NCT05784051View on ClinicalTrials.gov

Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

298

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2027

Conditions
Premature Ventricular ContractionsVentricular Dysfunction, Left
Interventions
DRUG

Experimental group

medical treatment including drug administration ± catheter ablation (Ablation can be performed if the PVC burden remain \>10% after 2 lines of AAD treatment).

DRUG

Control group

patients of this group have no therapeutic or no treatment modification such as drug therapy

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT05784051 - Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS | Biotech Hunter | Biotech Hunter